UCA1 and urinary bladder cancer: Moreover, Zhen et al. designed gRNAs specific to UCA1 and demonstrated significant knockdown of lncRNA UCA1 when transfected into 5637 and T24 bladder cancer cells with CRISPR/Cas9 systems targeting UCA1 [104].